nodes	percent_of_prediction	percent_of_DWPC	metapath
Mirabegron—CYP2D6—Parkinson's disease	0.527	0.583	CbGaD
Mirabegron—ABCB1—Parkinson's disease	0.376	0.417	CbGaD
Mirabegron—Labetalol—CYP2D6—Parkinson's disease	0.00102	0.433	CrCbGaD
Mirabegron—Propafenone—CYP2D6—Parkinson's disease	0.000777	0.331	CrCbGaD
Mirabegron—Propafenone—ABCB1—Parkinson's disease	0.000555	0.236	CrCbGaD
Mirabegron—ALB—Platelet activation, signaling and aggregation—SOD1—Parkinson's disease	8.59e-05	0.000907	CbGpPWpGaD
Mirabegron—CYP2D6—Biological oxidations—COMT—Parkinson's disease	8.5e-05	0.000898	CbGpPWpGaD
Mirabegron—CYP2D6—Biological oxidations—GSTP1—Parkinson's disease	8.46e-05	0.000893	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—ADRBK1—Parkinson's disease	8.44e-05	0.000892	CbGpPWpGaD
Mirabegron—ALB—Selenium Micronutrient Network—IL1B—Parkinson's disease	8.44e-05	0.000891	CbGpPWpGaD
Mirabegron—CYP2D6—Biological oxidations—MAOA—Parkinson's disease	8.44e-05	0.000891	CbGpPWpGaD
Mirabegron—CYP2D6—Metapathway biotransformation—COMT—Parkinson's disease	8.38e-05	0.000885	CbGpPWpGaD
Mirabegron—CYP2D6—Metapathway biotransformation—GSTP1—Parkinson's disease	8.34e-05	0.000881	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—PDYN—Parkinson's disease	8.32e-05	0.000879	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—DRD2—Parkinson's disease	8.18e-05	0.000864	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—HTR7—Parkinson's disease	8.18e-05	0.000864	CbGpPWpGaD
Mirabegron—ALB—Platelet activation, signaling and aggregation—IGF2—Parkinson's disease	8.16e-05	0.000861	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—Parkinson's disease	8.07e-05	0.000852	CbGpPWpGaD
Mirabegron—ABCB1—Allograft Rejection—IL1B—Parkinson's disease	8.06e-05	0.000851	CbGpPWpGaD
Mirabegron—ABCB1—Allograft Rejection—CASP3—Parkinson's disease	8.04e-05	0.000849	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—Parkinson's disease	7.94e-05	0.000839	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—GFAP—Parkinson's disease	7.83e-05	0.000827	CbGpPWpGaD
Mirabegron—CYP2D6—Biological oxidations—GSTM1—Parkinson's disease	7.77e-05	0.000821	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—GRM5—Parkinson's disease	7.74e-05	0.000817	CbGpPWpGaD
Mirabegron—ALB—Folate Metabolism—TNF—Parkinson's disease	7.71e-05	0.000814	CbGpPWpGaD
Mirabegron—ALB—Platelet activation, signaling and aggregation—HGF—Parkinson's disease	7.7e-05	0.000814	CbGpPWpGaD
Mirabegron—CYP2D6—Metapathway biotransformation—GSTM1—Parkinson's disease	7.67e-05	0.00081	CbGpPWpGaD
Mirabegron—ALB—Vitamin B12 Metabolism—IL6—Parkinson's disease	7.65e-05	0.000808	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—DDC—Parkinson's disease	7.6e-05	0.000803	CbGpPWpGaD
Mirabegron—SLCO1A2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	7.55e-05	0.000797	CbGpPWpGaD
Mirabegron—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	7.33e-05	0.000774	CbGpPWpGaD
Mirabegron—SLCO1A2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	7.25e-05	0.000765	CbGpPWpGaD
Mirabegron—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	7.23e-05	0.000764	CbGpPWpGaD
Mirabegron—ADRB3—GPCR downstream signaling—EDN1—Parkinson's disease	7.21e-05	0.000761	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—GSTA4—Parkinson's disease	7.18e-05	0.000758	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	7.09e-05	0.000749	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	7.08e-05	0.000748	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—Parkinson's disease	7.05e-05	0.000745	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—FGF20—Parkinson's disease	6.79e-05	0.000717	CbGpPWpGaD
Mirabegron—ALB—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	6.74e-05	0.000712	CbGpPWpGaD
Mirabegron—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	6.7e-05	0.000708	CbGpPWpGaD
Mirabegron—ALB—Metabolism—ND3—Parkinson's disease	6.67e-05	0.000705	CbGpPWpGaD
Mirabegron—ALB—Metabolism—MCCC1—Parkinson's disease	6.67e-05	0.000705	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—DDC—Parkinson's disease	6.67e-05	0.000704	CbGpPWpGaD
Mirabegron—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	6.61e-05	0.000698	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—ADORA2A—Parkinson's disease	6.58e-05	0.000695	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—EDN1—Parkinson's disease	6.55e-05	0.000691	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—PLA2G6—Parkinson's disease	6.46e-05	0.000682	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—MAOB—Parkinson's disease	6.4e-05	0.000676	CbGpPWpGaD
Mirabegron—ADRB3—GPCR downstream signaling—HTR2A—Parkinson's disease	6.31e-05	0.000666	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—GSTA4—Parkinson's disease	6.3e-05	0.000665	CbGpPWpGaD
Mirabegron—ALB—Metabolism—TALDO1—Parkinson's disease	6.27e-05	0.000663	CbGpPWpGaD
Mirabegron—ALB—Metabolism—OMD—Parkinson's disease	6.27e-05	0.000663	CbGpPWpGaD
Mirabegron—ALB—Folate Metabolism—IL6—Parkinson's disease	6.22e-05	0.000657	CbGpPWpGaD
Mirabegron—BCHE—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	6.22e-05	0.000657	CbGpPWpGaD
Mirabegron—ALB—Transmembrane transport of small molecules—CP—Parkinson's disease	6.2e-05	0.000655	CbGpPWpGaD
Mirabegron—ALB—Selenium Micronutrient Network—TNF—Parkinson's disease	6.12e-05	0.000647	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	6.09e-05	0.000643	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—INSR—Parkinson's disease	6.07e-05	0.000641	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—FGB—Parkinson's disease	5.96e-05	0.00063	CbGpPWpGaD
Mirabegron—ALB—Metabolism—NDUFB11—Parkinson's disease	5.95e-05	0.000628	CbGpPWpGaD
Mirabegron—BCHE—Metabolism of proteins—IGF2—Parkinson's disease	5.94e-05	0.000627	CbGpPWpGaD
Mirabegron—ABCB1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	5.91e-05	0.000624	CbGpPWpGaD
Mirabegron—ABCB1—Allograft Rejection—TNF—Parkinson's disease	5.85e-05	0.000618	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—ND3—Parkinson's disease	5.85e-05	0.000618	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—MCCC1—Parkinson's disease	5.85e-05	0.000618	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—FGB—Parkinson's disease	5.74e-05	0.000606	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—HTR2A—Parkinson's disease	5.73e-05	0.000605	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—HTR1A—Parkinson's disease	5.71e-05	0.000603	CbGpPWpGaD
Mirabegron—ALB—Metabolism—GCH1—Parkinson's disease	5.67e-05	0.000599	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—PLA2G6—Parkinson's disease	5.67e-05	0.000599	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—TAC1—Parkinson's disease	5.62e-05	0.000594	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—MAOB—Parkinson's disease	5.61e-05	0.000593	CbGpPWpGaD
Mirabegron—CYP3A4—Biological oxidations—COMT—Parkinson's disease	5.56e-05	0.000587	CbGpPWpGaD
Mirabegron—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	5.53e-05	0.000584	CbGpPWpGaD
Mirabegron—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	5.52e-05	0.000583	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—DRD1—Parkinson's disease	5.51e-05	0.000582	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—ND3—Parkinson's disease	5.51e-05	0.000582	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—MCCC1—Parkinson's disease	5.51e-05	0.000582	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—TALDO1—Parkinson's disease	5.5e-05	0.000581	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—OMD—Parkinson's disease	5.5e-05	0.000581	CbGpPWpGaD
Mirabegron—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	5.48e-05	0.000579	CbGpPWpGaD
Mirabegron—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	5.45e-05	0.000576	CbGpPWpGaD
Mirabegron—ABCB1—Transmembrane transport of small molecules—CP—Parkinson's disease	5.43e-05	0.000574	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—DRD3—Parkinson's disease	5.34e-05	0.000564	CbGpPWpGaD
Mirabegron—BCHE—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	5.34e-05	0.000564	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—NDUFB11—Parkinson's disease	5.21e-05	0.000551	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—TALDO1—Parkinson's disease	5.18e-05	0.000547	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—OMD—Parkinson's disease	5.18e-05	0.000547	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	5.12e-05	0.000541	CbGpPWpGaD
Mirabegron—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	5.08e-05	0.000537	CbGpPWpGaD
Mirabegron—ALB—Metabolism—DBH—Parkinson's disease	5.06e-05	0.000534	CbGpPWpGaD
Mirabegron—ALB—Metabolism—GBA—Parkinson's disease	5.06e-05	0.000534	CbGpPWpGaD
Mirabegron—ALB—Metabolism—FBP1—Parkinson's disease	5.06e-05	0.000534	CbGpPWpGaD
Mirabegron—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	5.01e-05	0.000529	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—ADRBK1—Parkinson's disease	4.99e-05	0.000527	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—GCH1—Parkinson's disease	4.97e-05	0.000525	CbGpPWpGaD
Mirabegron—ALB—Selenium Micronutrient Network—IL6—Parkinson's disease	4.94e-05	0.000522	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—NDUFB11—Parkinson's disease	4.91e-05	0.000519	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—DRD2—Parkinson's disease	4.83e-05	0.00051	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—HTR7—Parkinson's disease	4.83e-05	0.00051	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—CYP2D6—Parkinson's disease	4.75e-05	0.000502	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—GCH1—Parkinson's disease	4.69e-05	0.000495	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—CTGF—Parkinson's disease	4.67e-05	0.000493	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—GBA—Parkinson's disease	4.43e-05	0.000468	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—DBH—Parkinson's disease	4.43e-05	0.000468	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—FBP1—Parkinson's disease	4.43e-05	0.000468	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—SOD1—Parkinson's disease	4.43e-05	0.000468	CbGpPWpGaD
Mirabegron—ALB—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	4.42e-05	0.000467	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—CYP2E1—Parkinson's disease	4.35e-05	0.000459	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—NQO1—Parkinson's disease	4.3e-05	0.000454	CbGpPWpGaD
Mirabegron—ALB—Transmembrane transport of small molecules—CYCS—Parkinson's disease	4.24e-05	0.000448	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—TH—Parkinson's disease	4.24e-05	0.000447	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—ABL1—Parkinson's disease	4.22e-05	0.000446	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—IGF2—Parkinson's disease	4.2e-05	0.000444	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—FBP1—Parkinson's disease	4.18e-05	0.000441	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—DBH—Parkinson's disease	4.18e-05	0.000441	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—GBA—Parkinson's disease	4.18e-05	0.000441	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—CYP2D6—Parkinson's disease	4.17e-05	0.00044	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—CTGF—Parkinson's disease	4.09e-05	0.000432	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—CYCS—Parkinson's disease	4.07e-05	0.00043	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—IGF2—Parkinson's disease	4.05e-05	0.000427	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—HGF—Parkinson's disease	3.97e-05	0.000419	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	3.97e-05	0.000419	CbGpPWpGaD
Mirabegron—BCHE—Metabolism of proteins—INS—Parkinson's disease	3.94e-05	0.000416	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—IGF1R—Parkinson's disease	3.91e-05	0.000413	CbGpPWpGaD
Mirabegron—ABCB1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	3.87e-05	0.000409	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—EDN1—Parkinson's disease	3.87e-05	0.000408	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—CYP2E1—Parkinson's disease	3.81e-05	0.000403	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—NQO1—Parkinson's disease	3.77e-05	0.000398	CbGpPWpGaD
Mirabegron—ABCB1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	3.72e-05	0.000393	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—TH—Parkinson's disease	3.72e-05	0.000393	CbGpPWpGaD
Mirabegron—ALB—Metabolism—DDC—Parkinson's disease	3.71e-05	0.000392	CbGpPWpGaD
Mirabegron—ALB—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	3.69e-05	0.00039	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	3.65e-05	0.000385	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ND3—Parkinson's disease	3.6e-05	0.000381	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—MCCC1—Parkinson's disease	3.6e-05	0.000381	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—COMT—Parkinson's disease	3.6e-05	0.00038	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—GSTP1—Parkinson's disease	3.59e-05	0.000379	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—MAOA—Parkinson's disease	3.58e-05	0.000378	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—CYCS—Parkinson's disease	3.57e-05	0.000377	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—NGF—Parkinson's disease	3.55e-05	0.000375	CbGpPWpGaD
Mirabegron—ALB—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	3.54e-05	0.000374	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—HMOX1—Parkinson's disease	3.54e-05	0.000373	CbGpPWpGaD
Mirabegron—ALB—Metabolism—GSTA4—Parkinson's disease	3.51e-05	0.00037	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	3.46e-05	0.000366	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—ABCB1—Parkinson's disease	3.39e-05	0.000358	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—TALDO1—Parkinson's disease	3.39e-05	0.000358	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—OMD—Parkinson's disease	3.39e-05	0.000358	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—HTR2A—Parkinson's disease	3.38e-05	0.000357	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—GSTM1—Parkinson's disease	3.29e-05	0.000348	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—DDC—Parkinson's disease	3.25e-05	0.000344	CbGpPWpGaD
Mirabegron—ABCB1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	3.23e-05	0.000341	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	3.21e-05	0.000339	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—COMT—Parkinson's disease	3.16e-05	0.000334	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PLA2G6—Parkinson's disease	3.16e-05	0.000333	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—GPX1—Parkinson's disease	3.16e-05	0.000333	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—GSTP1—Parkinson's disease	3.15e-05	0.000332	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—APOE—Parkinson's disease	3.14e-05	0.000332	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—MAOA—Parkinson's disease	3.14e-05	0.000331	CbGpPWpGaD
Mirabegron—ALB—Metabolism—MAOB—Parkinson's disease	3.12e-05	0.00033	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—HMOX1—Parkinson's disease	3.1e-05	0.000328	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—GSTA4—Parkinson's disease	3.07e-05	0.000324	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—DDC—Parkinson's disease	3.07e-05	0.000324	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—GCH1—Parkinson's disease	3.06e-05	0.000324	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—ABCB1—Parkinson's disease	2.98e-05	0.000315	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	2.97e-05	0.000314	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—MTHFR—Parkinson's disease	2.91e-05	0.000308	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—GSTA4—Parkinson's disease	2.89e-05	0.000306	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—GSTM1—Parkinson's disease	2.89e-05	0.000305	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	2.89e-05	0.000305	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—GPX1—Parkinson's disease	2.77e-05	0.000292	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PLA2G6—Parkinson's disease	2.77e-05	0.000292	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—MAOB—Parkinson's disease	2.74e-05	0.000289	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—DBH—Parkinson's disease	2.73e-05	0.000288	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—FBP1—Parkinson's disease	2.73e-05	0.000288	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—GBA—Parkinson's disease	2.73e-05	0.000288	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—APOE—Parkinson's disease	2.71e-05	0.000286	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—INS—Parkinson's disease	2.69e-05	0.000284	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	2.61e-05	0.000275	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—MAOB—Parkinson's disease	2.58e-05	0.000273	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—MTHFR—Parkinson's disease	2.55e-05	0.00027	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—APOE—Parkinson's disease	2.38e-05	0.000251	CbGpPWpGaD
Mirabegron—ALB—Metabolism—CYP2D6—Parkinson's disease	2.32e-05	0.000245	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—INS—Parkinson's disease	2.32e-05	0.000245	CbGpPWpGaD
Mirabegron—ALB—Metabolism—CTGF—Parkinson's disease	2.28e-05	0.000241	CbGpPWpGaD
Mirabegron—ALB—Metabolism—CYP2E1—Parkinson's disease	2.12e-05	0.000224	CbGpPWpGaD
Mirabegron—ALB—Metabolism—NQO1—Parkinson's disease	2.1e-05	0.000222	CbGpPWpGaD
Mirabegron—ALB—Metabolism—TH—Parkinson's disease	2.07e-05	0.000219	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CYP2D6—Parkinson's disease	2.03e-05	0.000215	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—INS—Parkinson's disease	2.03e-05	0.000215	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—DDC—Parkinson's disease	2e-05	0.000212	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—CASP3—Parkinson's disease	2e-05	0.000211	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CTGF—Parkinson's disease	2e-05	0.000211	CbGpPWpGaD
Mirabegron—ALB—Metabolism—CYCS—Parkinson's disease	1.99e-05	0.00021	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—IL6—Parkinson's disease	1.99e-05	0.00021	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—GSTA4—Parkinson's disease	1.89e-05	0.0002	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CTGF—Parkinson's disease	1.88e-05	0.000199	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CYP2E1—Parkinson's disease	1.86e-05	0.000197	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—NQO1—Parkinson's disease	1.84e-05	0.000194	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—MAPK8—Parkinson's disease	1.84e-05	0.000194	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—TH—Parkinson's disease	1.81e-05	0.000192	CbGpPWpGaD
Mirabegron—ALB—Metabolism—COMT—Parkinson's disease	1.76e-05	0.000186	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	1.75e-05	0.000185	CbGpPWpGaD
Mirabegron—ALB—Metabolism—GSTP1—Parkinson's disease	1.75e-05	0.000185	CbGpPWpGaD
Mirabegron—ALB—Metabolism—MAOA—Parkinson's disease	1.75e-05	0.000185	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CYCS—Parkinson's disease	1.74e-05	0.000184	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—NQO1—Parkinson's disease	1.73e-05	0.000183	CbGpPWpGaD
Mirabegron—ALB—Metabolism—HMOX1—Parkinson's disease	1.73e-05	0.000182	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—TH—Parkinson's disease	1.71e-05	0.000181	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	1.7e-05	0.00018	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—MAOB—Parkinson's disease	1.69e-05	0.000178	CbGpPWpGaD
Mirabegron—ALB—Metabolism—ABCB1—Parkinson's disease	1.66e-05	0.000175	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CYCS—Parkinson's disease	1.64e-05	0.000173	CbGpPWpGaD
Mirabegron—ALB—Metabolism—GSTM1—Parkinson's disease	1.61e-05	0.00017	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—COMT—Parkinson's disease	1.54e-05	0.000163	CbGpPWpGaD
Mirabegron—ALB—Metabolism—GPX1—Parkinson's disease	1.54e-05	0.000163	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—GSTP1—Parkinson's disease	1.53e-05	0.000162	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—MAOA—Parkinson's disease	1.53e-05	0.000162	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—HMOX1—Parkinson's disease	1.51e-05	0.00016	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—COMT—Parkinson's disease	1.45e-05	0.000153	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—GSTP1—Parkinson's disease	1.45e-05	0.000153	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—MAOA—Parkinson's disease	1.44e-05	0.000152	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—HMOX1—Parkinson's disease	1.43e-05	0.000151	CbGpPWpGaD
Mirabegron—ALB—Metabolism—MTHFR—Parkinson's disease	1.42e-05	0.00015	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—GSTM1—Parkinson's disease	1.41e-05	0.000149	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—ABCB1—Parkinson's disease	1.37e-05	0.000145	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—GPX1—Parkinson's disease	1.35e-05	0.000143	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—GSTM1—Parkinson's disease	1.33e-05	0.00014	CbGpPWpGaD
Mirabegron—ALB—Metabolism—APOE—Parkinson's disease	1.32e-05	0.00014	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—GPX1—Parkinson's disease	1.27e-05	0.000134	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	1.25e-05	0.000132	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—MTHFR—Parkinson's disease	1.25e-05	0.000132	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CTGF—Parkinson's disease	1.23e-05	0.00013	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—MTHFR—Parkinson's disease	1.17e-05	0.000124	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—IL6—Parkinson's disease	1.17e-05	0.000124	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—APOE—Parkinson's disease	1.16e-05	0.000123	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	1.15e-05	0.000121	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—NQO1—Parkinson's disease	1.13e-05	0.00012	CbGpPWpGaD
Mirabegron—ALB—Metabolism—INS—Parkinson's disease	1.13e-05	0.00012	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—TH—Parkinson's disease	1.12e-05	0.000118	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—APOE—Parkinson's disease	1.09e-05	0.000116	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CYCS—Parkinson's disease	1.07e-05	0.000113	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—INS—Parkinson's disease	9.91e-06	0.000105	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—COMT—Parkinson's disease	9.5e-06	0.0001	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—GSTP1—Parkinson's disease	9.46e-06	9.99e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—MAOA—Parkinson's disease	9.43e-06	9.96e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—INS—Parkinson's disease	9.34e-06	9.87e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—HMOX1—Parkinson's disease	9.33e-06	9.85e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ABCB1—Parkinson's disease	8.95e-06	9.45e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—GSTM1—Parkinson's disease	8.69e-06	9.18e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—GPX1—Parkinson's disease	8.32e-06	8.79e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—MTHFR—Parkinson's disease	7.68e-06	8.11e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—APOE—Parkinson's disease	7.15e-06	7.55e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—INS—Parkinson's disease	6.11e-06	6.45e-05	CbGpPWpGaD
